Bruce Kovner

Filings by Bruce Kovner span 2 companies, the busiest being Madrigal Pharmaceuticals, Inc. and Celator Pharmaceuticals Inc. Between 17 November 2006 and 12 July 2016, the trades on record add up to 139 filings.

Market trades split into 54 purchases (€63.2M) and 35 sales (€6.9M). The net balance comes to €56.2M on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 20 share grants.

A typical purchase (the median) is worth €130k. Looking at 54 purchases old enough to measure, the stock rose over the following 90 days in 54% of cases; the median change was +1.5%. This is a record of the past, not a forecast.

The newest entry dates from 12 July 2016: a transaction of €43.5M, in Celator Pharmaceuticals Inc. The latest purchase dates back some time: it was published 4,217 days ago, on 8 April 2015. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.